Novacyt S.A. NVYTF · Stock Open Novacyt S.A. in new tab
Novacyt S.A. Analysis (NVYTF)
Is Novacyt S.A. a good investment? Novacyt S.A. (NVYTF) is currently trading at 0.5710 USD.
Earnings Schedule: Novacyt S.A. is expected to release its next earnings report on Sept. 24, 2026.
Investor FAQ
Does Novacyt S.A. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Novacyt S.A.?
Novacyt S.A. is classified as a Stock. You can compare it against 5 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Sept. 24, 2026. The company currently has a trailing EPS of -0.45.
Company Profile
Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. It operates in the United Kingdom, France, Europe, the United States, the Asia Pacific, the Middle East, and Africa. The company was incorporated in 2006 and is based in Le Vésinet, France.
Community Discussion